Physician profile
Cheney Yee Chang
NPI 1245483544
$16,103.67
in general payments reported to CMS, 2019-2025
33 companies · $1,864 in 2025
The $1,864 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,744 · 2022: $4,789 · 2023: $4,704 · 2024: $3,003 · 2025: $1,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,187 · Education: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,186.61 |
| Education | $383.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,980.62 | 2021-2025 | |
| Janssen Biotech, INC. | $1,634.62 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $1,436.43 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $1,196.37 | 2021-2025 | Ilumya, Absorica Ld, Winlevi |
| Epi Health, LLC | $993.56 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $839.01 | 2021-2025 | Dupixent |
| Amgen INC. | $813.85 | 2021-2025 | Otezla, Otezla |
| Incyte Corporation | $717.26 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $703.19 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $631.51 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $587.21 | 2023-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $540.54 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $527.86 | 2021-2025 | Aklief, Oracea, Nemluvio |
| Dermavant Sciences, INC. | $527.59 | 2023-2024 | Vtama |
| Pfizer INC. | $500.35 | 2021-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $469.51 | 2021-2023 | |
| Almirall LLC | $403.24 | 2021-2024 | Klisyri |
| Ucb, INC. | $359.14 | 2021-2025 | Bimzelx, Cimzia |
| Verrica Pharmaceuticals INC. | $299.17 | 2023-2024 | Ycanth |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $267.53 | 2021-2025 | Jublia, Cabtreo, Arazlo |
| Leo Pharma INC. | $215.18 | 2021-2025 | Adbry, Anzupgo |
| Allergan, INC. | $171.32 | 2022 | |
| Journey Medical Corporation | $54.17 | 2022-2025 | |
| Merz North America, INC. | $43.95 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.06 | 2023-2024 | Spevigo |
| Sanofi US Services INC. | $26.60 | 2024 | |
| Nabriva Therapeutics, Plc | $23.93 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $21.82 | 2021 | |
| Dermira, INC. | $19.64 | 2021 | |
| Mission Pharmacal Company | $18.26 | 2022 | |
| Botanix Sb INC | $13.94 | 2025 | Sofdra |
| Vyne Pharmaceuticals INC. | $13.33 | 2021 | |
| Kerecis Limited | $10.91 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheney Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.